Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Stroke patients ...
The effects and risks of the use of intravenous thrombolysis between 4.5 and 24 hours after the onset of a posterior circulation ischemic stroke are not well studied. In a trial conducted in China, we ...
As the COVID-19 pandemic swells, experts around the globe are working to determine which existing medicines might help patients experiencing severe illness. Malaria drug chloroquine has gotten a lot ...
An individual patient-level meta-analysis shows that tenecteplase, a next-generation thrombolytic, is at least as effective as alteplase for acute stroke — and may be superior.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback